Abstract:Purpose: The changes on cell expansion and anti-tumor activity of mouse tumor-specific T cells activated by anti-CD3 monoclonal antibody (McAb) were investigated. The goal of this study is to find out more efficient method for tumor adoptive immunotherapy. Methods: Tumor-specific T cells from tumor-immunized mice were obtained by in vitro activation of anti-CD3 monoclonal antibody. The changes on cell expansion and anti-tumor activity as well as phenotype were studied. Four different culture modes were applied in this experiment: (1) cultured in anti-CD3 McAb alone (anti-CD3 group); (2) cultured in 20000 u/L rIL-2 alone (IL-2 group); (3) activated by anti-CD3 McAb for 48 hr and then cultured in 20000 u/L rIL-2 alone (CD3 -IL-2 group); (4) activated by anti-CD3 McAb for 48 hr and then cultured in CD3 McAb plus 20000 u/L rIL-2 (CD3 +IL-2 group). Results: The cells in CD3 -IL-2 group and CD3 +IL-2 group increased and expanded 780 folds and 610 folds respectively within 20 day. The maximum anti-tumor activities of both groups were 41.8% and 91.3% respectively on day 12. However, the continuous use of anti-CD3 McAb alone had neither proliferative effect nor anti-tumor activity. The IL-2 group maintained a low level of proliferation within 20 days and showed its maximum anti-tumor activity of 30.2% on day 12. The study of cell phenotype by FACS analysis on day 6 indicated that >98% effective cells of both the CD3 -IL-2 group and CD3 +IL-2 group were Thy1.2+ cells. On day 20 Thy1.2+ cells of CD3 +IL-2 group was still 98.8% while Thy1.2+ cell of CD3 -IL-2 group was only 44.4%. There were also differences in CD4 + and CD8 + between the 2 groups. Conclusions: The tumor-specific T cells cultured in the presence of the combination of anti-CD3 McAb and low dosed rIL-2 may facilitate a rapid expansion and long term maintenance of higher cytotoxicity. In general, this is a promising approach in tumor adoptive immunotherapy.

Comparison of Assistant Effects among Assistant Molecules on T Cell Activation by Superantigen

Il-12 Augments Antigen-Dependent Proliferation Of Activated Lymphocytes-T

V Beta Specificity of Superantigen TSST-1 Plus CD28 Costimulation Without APCs.

A Comparative Study on the Mechanisms of Innate Immune Responses in Mice Induced by Alum and Actinidia Eriantha Polysaccharide.

Anti-CD28 McAb Enhance Anti-tumor Activity of Tumor Specific Cytotoxic T Lymphocyte in Vitro and in Vivo

Difference of Responsiveness in Murine T Cell Populations Reactive with Superantigen SEA

Assessment Of Re-188 Marked Anti Mhc Class Ii Antibody By Peripheral Blood Mononuclear Cells Stimulated By Donor Alloantigen

Enhancement of anti-CD4 mAb on anti-tumor activity of tumor-specific T cells activated by rIL-2 and anti-CD3 mAb

Effect of Mycophenolic Acid on T Lymphocyte Proliferation and Cytokine Expression in Vitro

Effect of anti-CD3 monoclonal antibody on expansion and anti-tumor activity of tumor specific T cells

T cell activation through TCR/-CD3 complex. IL-2 production of T cell clones stimulated with anti-CD3 without cross-linkage.

The Effect of Alpha-Melanocyte-stimulating Hormone on CD28 and CD86 Molecule and Th1/Th2 Cytokines in Collagen-Induced Arthritis Rats

[Regulation of CD3, CD4 and CD8 expressions on PMA-activated human peripheral T cells].

Effects of PMA on CD4 expression on T-helper surface in vitro

Anti-tumor Effects of Mouse CTL of Non-Specific Expansion

Effect of CsA on T Cell Activation CD28 Pathway

Effects of Cyclosporin A on CD28/CTLA4 and CD40/CD40L Co-Stimulated Lymphocyte Proliferation

Cd8(+) Cytotoxic T-Apc Stimulate Central Memoiry Cd8(+) T Cell Responses Via Acquired Peptide-Mhc Class I Complexes And Cd80 Costimulation, And Rl-2 Secretion

Enhancement of sub-optimal doses of Con A-mediated activation and apoptosis of thymocytes by immobilized PF18-3 McAb

[Effects of Humanized Recombinant CD25 Monoclonal Antibody on Activation and Proliferation of T Lymphocytes].

Effect of GM-CSF on the T Helper Cell Response Induced by Gene Immunization with Antigenized Antibody